Uncommon but real: GI upset, and rare hypersensitivity
As a result, reliance on these medications has decreased in preference for newer therapies, such as insulin pumps, sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, which have demonstrated notable efficacy
Yes Mounjaro (tirzepatide) works through a similar mechanism and can trigger the same weight-loss-related shedding
Customized Treatment Plans : No two faces are the same, and neither are our treatment plans
For context, about 60% of CagriSema participants hit the 20% weight-loss mark, and nearly 1 in 4 lost 30% or more
From there, you're matched with a licensed clinician who reviews your profile and discusses options